PNC Financial Services Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $984K | Sell |
|
|||||
|
2025
Q2 | $973K | Sell |
|
|||||
|
2025
Q1 | $917K | Buy |
|
|||||
|
2024
Q4 | $1.28M | Sell |
|
|||||
|
2024
Q3 | $1.07M | Sell |
|
|||||
|
2024
Q2 | $1.01M | Sell |
|
|||||
|
2024
Q1 | $960K | Buy |
|
|||||
|
2023
Q4 | $674K | Sell |
|
|||||
|
2023
Q3 | $724K | Buy |
|
|||||
|
2023
Q2 | $528K | Sell |
|
|||||
|
2023
Q1 | $694K | Buy |
|
|||||
|
2022
Q4 | $687K | Buy |
|
|||||
|
2022
Q3 | $599K | Sell |
|
|||||
|
2022
Q2 | $635K | Sell |
|
|||||
|
2022
Q1 | $1.12M | Buy |
|
|||||
|
2021
Q4 | $849K | Sell |
|
|||||
|
2021
Q3 | $1.05M | Sell |
|
|||||
|
2021
Q2 | $1.23M | Sell |
|
|||||
|
2021
Q1 | $1.49M | Buy |
|
|||||
|
2020
Q4 | $1.05M | Sell |
|
|||||
|
2020
Q3 | $1.03M | Sell |
|
|||||
|
2020
Q2 | $1.46M | Sell |
|
|||||
|
2020
Q1 | $1.12M | Sell |
|
|||||
|
2019
Q4 | $1.26M | Sell |
|
|||||
|
2019
Q3 | $911K | Buy |
|
|||||
|
2019
Q2 | $1.14M | Sell |
|
|||||
|
2019
Q1 | $2.46M | Sell |
|
|||||
|
2018
Q4 | $2.43M | Sell |
|
|||||
|
2018
Q3 | $3.94M | Sell |
|
|||||
|
2018
Q2 | $4.56M | Sell |
|
|||||
|
2018
Q1 | $3.64M | Sell |
|
|||||
|
2017
Q4 | $4.77M | Sell |
|
|||||
|
2017
Q3 | $6.52M | Sell |
|
|||||
|
2017
Q2 | $17.5M | Sell |
|
|||||
|
2017
Q1 | $19.8M | Sell |
|
|||||
|
2016
Q4 | $26.3M | Sell |
|
|||||
|
2016
Q3 | $45.1M | Sell |
|
|||||
|
2016
Q2 | $55.1M | Sell |
|
|||||
|
2016
Q1 | $90.1M | Sell |
|
|||||
|
2015
Q4 | $113M | Buy |
|
|||||
|
2015
Q3 | $87.4M | Buy |
|
|||||
|
2015
Q2 | $80.2M | Sell |
|
|||||
|
2015
Q1 | $87.5M | Buy |
|
|||||
|
2014
Q4 | $76.8M | Buy |
|
|||||
|
2014
Q3 | $71.3M | Buy |
|
|||||
|
2014
Q2 | $53M | Sell |
|
|||||
|
2014
Q1 | $57.3M | Sell |
|
|||||
|
2013
Q4 | $43.7M | Sell |
|
|||||
|
2013
Q3 | $46.6M | Buy |
|
|||||
|
2013
Q2 | $47.7M | Buy |
|